Filing Details
- Accession Number:
- 0001562180-20-006681
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-12 17:55:56
- Reporting Period:
- 2020-11-09
- Accepted Time:
- 2020-11-12 17:55:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1395937 | Syndax Pharmaceuticals Inc | SNDX | Pharmaceutical Preparations (2834) | 320162505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1654430 | Briggs Morrison | C/O Syndax Pharmaceuticals, Inc. 35 Gatehouse Drive, Building D, Floor 3 Waltham MA 02451 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-09 | 62,938 | $7.20 | 109,503 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-09 | 62,938 | $20.04 | 46,565 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-10 | 17,466 | $7.20 | 64,031 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-10 | 17,466 | $20.06 | 46,565 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to buy) | Disposition | 2020-11-09 | 62,938 | $0.00 | 62,938 | $7.20 |
| Common Stock | Stock Options (Right to buy) | Disposition | 2020-11-10 | 17,466 | $0.00 | 17,466 | $7.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-06-01 | No | 4 | M | Direct | |
| 0 | 2025-06-01 | No | 4 | M | Direct |
Footnotes
- The number of securities reported reflects the acquisition of 2,665 shares by the Reporting Person on 07/31/2020 pursuant to the Issuer's Employee Stock Purchase Plan.
- The sale prices ranged from $20.00 to $20.21.
- The sale prices ranged from $20.00 to $20.29.
- This option is fully vested.
Billionaire Hedge Funds
